FSAG
MRNA icon

Financial Solutions Advisory Group’s Moderna MRNA Stock Holding History

Financial Solutions Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
5,137
-16
-0.3% -$828 0.05% 128
2026
Q1 		$262K Buy
+5,153
New +$240K 0.04% 151

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Financial Solutions Advisory Group's MRNA Position: Q2 2026 in Review

Financial Solutions Advisory Group reduced its Moderna (MRNA) stake by 0.31% in Q2 2026, selling an estimated $828 and leaving 5,137 shares worth $393K. The position accounts for 0.05% of the portfolio, ranked #128.

Financial Solutions Advisory Group first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Financial Solutions Advisory Group held 5,137 shares of Moderna worth $393K as of Q2 2026.
  • Financial Solutions Advisory Group sold 16 Moderna shares in Q2 2026, an estimated $828.
  • Moderna made up 0.05% of Financial Solutions Advisory Group's portfolio in Q2 2026, its #128 holding.
  • Financial Solutions Advisory Group first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Financial Solutions Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.